Corient Capital Partners’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
Other funds holding VTRS
DSA
CCM
LCM
Corient Capital Partners's VTRS Position: Q3 2022 in Review
Corient Capital Partners increased its Viatris (VTRS) stake by 22% in Q3 2022, buying an estimated $22.8K and bringing the position to 12,837 shares worth $134K. The position accounts for 0.01% of the portfolio, ranked #635.
Corient Capital Partners first reported a position in VTRS in Q4 2016 and has held it in 9 quarters since. The position peaked at $2.41M in Q2 2017. 980 funds tracked by Wall St. Rank hold VTRS as of Q3 2022.
- Corient Capital Partners held 12,837 shares of Viatris worth $134K as of Q3 2022.
- Corient Capital Partners bought 2,320 Viatris shares in Q3 2022, an estimated $22.8K.
- Viatris made up 0.01% of Corient Capital Partners's portfolio in Q3 2022, its #635 holding.
- Corient Capital Partners first reported a position in Viatris in Q4 2016 and has held it in 9 quarters since.
- Corient Capital Partners's Viatris position peaked at $2.41M in Q2 2017.
- 980 funds tracked by Wall St. Rank held Viatris as of Q3 2022.
Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.